PURR · Hyperliquid Strategies Inc

Current Thesis

Hyperliquid Strategies' tokenization-led recovery depends on sustaining the September 18 rebound: a weekly close above $14.09 by 2026-10-09 would confirm near-term persistence, provided a daily close below $12.83 has not occurred first. This is a price-continuation hypothesis inferred from the new regulatory event and the adjusted market close, not demonstrated growth in the company's earnings.

The Securities and Exchange Commission (SEC) announced temporary, conditional relief for tokenized-stock venues on 2026-09-17. That establishes a regulatory development; it does not establish Hyperliquid's eligibility or incremental income for Hyperliquid Strategies. SEC announcement

For this new recovery leg, the narrative is accelerating — the September 17 regulatory announcement generated company-specific Benzinga coverage on September 17 and September 18, while the September 18 adjusted close reached $14.09. The classification describes renewed attention; broader participation remains unmeasured. The earlier continuation case remains invalidated by the 2026-09-10 close of $11.01 below its published $11.32 threshold.

Bullish and bearish views on Hyperliquid Strategies Inc

The model's bull view on Hyperliquid Strategies Inc (PURR), in brief: The regulatory event is real. The SEC's 2026-09-17 announcement permits qualifying venues to conduct certain tokenized-stock trading under conditional relief. This supports the subject of the renewed attention, although company-specific access remains unestablished. SEC… The bear view: Permission remains conditional and limited. Both cases follow in full.

Bull Case

• The regulatory event is real. The SEC's 2026-09-17 announcement permits qualifying venues to conduct certain tokenized-stock trading under conditional relief. This supports the subject of the renewed attention, although company-specific access remains unestablished. SEC announcement
• Financing has produced actual proceeds. The preliminary prospectus dated 2026-09-14 reports approximately $1.1 billion in aggregate gross proceeds received through the equity facility, against a $2.5 billion total commitment. Those are company financing figures; they do not establish an increase in net assets per diluted common share. September prospectus
• The prior objective was recovered. The adjusted market close of $14.09 on 2026-09-18 exceeded the $12.83 close recorded on 2026-08-27, which the September 11 research identified as the previous continuation objective. That supports a separate recovery hypothesis without reversing the earlier failure.

Bear Case

• Permission remains conditional and limited. Commissioner Mark Uyeda's 2026-09-17 statement describes permissioned venues subject to transparency requirements, safeguards, symbol limits and volume caps. A headline about tokenization therefore does not establish unrestricted access for Hyperliquid. SEC commissioner statement
• Additional resale supply is proposed. The prospectus dated 2026-09-14 covers potential resale of up to 160,000,000 additional common shares associated with the equity facility. Registration capacity is an observable supply mechanism, although the prospectus does not establish that all those shares have been issued or resold. September prospectus
• The preceding structure already failed. The 2026-09-10 adjusted close of $11.01 breached the prior $11.32 research threshold. The September 18 recovery supplies no evidence that future support breaches will be temporary.

Setup & Price Structure

The adjusted daily series records a $14.09 close, a three-month price increase of 53.2%, and a 14-period relative strength index (RSI) of 63.2 as of 2026-09-18. No moving-average value or slope accompanies that observation, so distance above a rising average is unmeasured.

The $12.83 market close from 2026-08-27 is the reclaimed historical reference selected for this new hypothesis. Treating it as support is an inference, falsified by a daily close below $12.83. The available observations do not establish repeated support tests or a completed base.

Benzinga's company-specific headlines on 2026-09-11, 2026-09-17 and 2026-09-18 document coverage clustering. They provide no short-interest count, options positioning or retail ownership measurement. The sample is too small to support a claim of forced covering; the refreshed case concerns an emerging regulatory narrative rather than an established squeeze.

Catalyst Calendar (next 30 days)

• 2026-09-24 — Short-interest publication. The scheduled release covers the September 15 settlement. It provides a positioning observation preceding the September 17 regulatory announcement, so it cannot establish covering in response to that announcement. Nasdaq short-interest calendar
• 2026-10-09 — Short-interest publication. The scheduled release covers the September 30 settlement, providing a later observation that includes the period following the regulatory news. Actual figures and a comparable earlier observation are required before attributing the recovery to changing short participation. Nasdaq short-interest calendar

As of 2026-09-20, no company-confirmed earnings date or Hyperliquid-specific implementation date is established in the available evidence for this window. The positioning releases do not resolve eligibility under the SEC exemption.

What Would Change Our Mind

Loss of the reclaimed August reference would break the new recovery structure: a daily close below $12.83 invalidates this case. Conversely, a weekly close above the September 18 reference close of $14.09 by 2026-10-09, before that breach, would satisfy the stated near-term continuation test. Failure to produce that weekly close by the deadline leaves the persistence forecast unfulfilled.

The economic interpretation requires separate evidence. Following the SEC's 2026-09-17 announcement, a named eligible venue, a documented connection to Hyperliquid, and company disclosures identifying resulting income would substantiate the proposed transmission to Hyperliquid Strategies. Price strength alone does not establish those links.

Correlation Notes

The historical annual-report disclosure recorded approximately 29.4 million HYPE tokens as of 2026-08-23, establishing a company-specific connection to the token's value. It is a dated treasury observation, not a current token count or a measured equity-to-token correlation. Fiscal 2026 annual report

Benzinga's 2026-09-18 market-movers coverage placed Hyperliquid Strategies alongside other rising crypto-related equities. That observation is insufficient to separate tokenization attention from a broader crypto move. This remains a single-name hypothesis; no synchronized return series establishes a sector relationship or a correlation coefficient.